KELLIE LOUGHRAN: Open Payments
NPI 1497228159 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 15 payments from 7 companies in 2025. Trend: 2023 $181 · 2024 $120 · 2025 $322
Food & beverage: $322
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 6 | $135 |
| Lilly USA, LLC | 3 | $55 |
| Astellas Pharma US Inc | 2 | $55 |
| Novo Nordisk Inc | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Seqirus USA Inc | 1 | $17 |
| Amphastar Pharmaceuticals, Inc. | 1 | $15 |
Products named: Veozah, NURTEC ODT, ELIQUIS, MOUNJARO, PREVNAR 20, Wegovy, INSPIRE, PAXLOVID.
Industry payments across DC — which companies pay providers there.
